Investment Summary

ArchiMed Invests In Ad-Tech

On January 1, 2020, private equity firm ArchiMed invested in medical products company Ad-Tech

Investment Highlights
  • This is ArchiMed’s 5th transaction in the Medical Products sector.
  • This is ArchiMed’s 2nd transaction in the United States.
  • This is ArchiMed’s 1st transaction in Wisconsin.

Investment Summary
Date 2020-01-01
Target Ad-Tech
Sector Medical Products
Investor(s) ArchiMed
Deal Type Growth Capital

Target

Ad-Tech

Oak Creek, Wisconsin, United States
Ad-Tech is a provider of consumables of electrodes for the surgical treatment of intractable epilepsy and devices for neurodiagnostic and neurosurgery. Ad-Tech was founded in 1983 and is based in Oak Creek, Wisconsin.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

ArchiMed

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2014
PE ASSETS 8.0B EUR
Size Mega
Type Sector Focused
DESCRIPTION

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €10 million to €1 billion per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.

DEAL STATS #
Overall 17 of 36
Sector (Medical Products) 5 of 9
Type (Growth Capital) 3 of 7
State (Wisconsin) 1 of 2
Country (United States) 2 of 9
Year (2020) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-12-09 DHG

Caerphilly, United Kingdom

DHG is a fully integrated developer and manufacturer of a range of innovative pressure care products designed to prevent medical issues such as pressure sores, which can lead to serious, sometimes life-threatening diseases. DHG was formed in 2009 and is based in Caerphilly, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-18 ActiGraph

Pensacola, Florida, United States

ActiGraph is a developer of wearable, remote monitoring technology for academic studies, and drug trials. ActiGraph’s mobility and sleep tracking hardware, software and analysis solutions are the most widely used research-grade monitoring systems for activity in the world. ActiGraph was founded in 2004 and is based in Pensacola, Florida.

Buy -
Mergr

Product

Company

Legal